Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Eur J Cancer ; 39(7): 996-1003, 2003 May.
Article in English | MEDLINE | ID: mdl-12706370

ABSTRACT

Nephrotoxicity is a side-effect and the main factor limiting the clinical use of cisplatin. In vivo, the administration of the cysteine-containing tripeptide glutathione (GSH) has been found to reduce nephrotoxicity, but the biochemical mechanism of this protective action is not fully understood. The present study was designed to gain insights into the mechanism by which GSH prevents cisplatin nephrotoxicity. We also wanted to verify the hypothesis of whether the protective action of GSH is mediated by products of the extracellular breakdown of GSH catalysed by gamma-glutamyl transpeptidase (GGT), an enzyme that is highly expressed in kidney tubular cells. The study was performed in HK-2 cells, derived from the immortalisation of human kidney proximal tubule cells. We investigated the influence of modulators of GGT activity and/or thiols on the antiproliferative activity of cisplatin and on the intracellular GSH content. We determined the antiproliferative activity of cisplatin, platinum cellular accumulation and DNA platination following precomplexing of the drug with thiols. The antiproliferative effect of cisplatin was minimally affected by the addition of GSH. However, when the antiproliferative assay was performed in the presence of glycyl-glycine (GlyGly), to serve as a transpeptidation acceptor and thus to stimulate GGT-mediated GSH catabolism, cisplatin-induced growth inhibition was largely prevented. This effect was not mediated through an increase of intracellular GSH levels, which were not affected by the GlyGly supplementation. The thiol dipeptide cysteinyl-glycine, i.e. the GSH catabolite generated by GGT activity, showed a higher reactivity against cisplatin in vitro than GSH, as was shown by the more rapid oxidation of its -SH groups. The cisplatin/GSH or cisplatin/cysteinyl-glycine adducts did not display an antiproliferative effect. However, 2 h precomplexing with GSH in the presence of GGT, or directly with the GSH catabolite cysteinyl-glycine, decreased the antiproliferative effect of cisplatin and drug-induced DNA platination to a greater extent than precomplexing with GSH alone. The results of the present study show that, in HK-2 cells, extracellular GSH decreases the antiproliferative effects of cisplatin only upon its hydrolysis by GGT, thereby supporting the hypothesis that the extracellular metabolism of GSH by GGT plays a role in modulating cisplatin nephrotoxicity. A primary role in the protection of HK-2 cells appears to be played by cysteinyl-glycine, the proximal product of the GGT-mediated hydrolysis of GSH, which shows a high reactivity against CDDP resulting in the rapid inactivation of the drug.


Subject(s)
Antineoplastic Agents/pharmacokinetics , Cisplatin/pharmacokinetics , Kidney Tubules, Proximal/metabolism , gamma-Glutamyltransferase/pharmacology , Antineoplastic Agents/adverse effects , Cell Line , Cisplatin/adverse effects , Glutathione/pharmacology , Humans , Inactivation, Metabolic , Kidney Diseases/chemically induced , Kidney Diseases/prevention & control , Sulfhydryl Compounds/metabolism
2.
Ren Fail ; 23(3-4): 331-7, 2001.
Article in English | MEDLINE | ID: mdl-11499549

ABSTRACT

P-glycoprotein (PGP) is an efflux pump physiologically expressed in the apical membrane of the proximal tubular cells. PGP may play a role in the elimination of exogenous substances such as chemotherapeutic drugs, calcium channel blockers and immunosuppressors. The involvement of renal PGP in the transport of endogenous substrates is under investigation. HK-2 is an immortalized proximal tubule cell line from normal adult human kidney, reported to retain a phenotype indicative of a well-differentiated state. No data regarding expression and/or activity of PGP in this cell line are available. The aim of this study was to ascertain the usefulness of HK-2 cell line to investigate the properties and roles of PGP in proximal tubular cells. PGP expression in HK-2 cells was determined by immunoblotting analysis using the monoclonal antibody C219. The activity of PGP was assessed by measuring the transport of the fluorescent probe Rhodamine 123 (R-123) in intact cell monostrates. The interactions of putative PGP modulators, including verapamil and cyclosporin A were also evaluated. Western blot revealed a C219 immunoreactive band of about 150 kDa consistent with the presence of PGP. HK-2 cells preloaded with R-123 rapidly effluxed the dye, the efflux being inhibited by verapamil. Verapamil and, to a major extent cyclosporin A, significantly increased R-123 intracellular accumulation. PGP immunoblottable amount was increased when cells were cultured in the presence of either cyclosporin A or dexamethasone. The results suggest that the HK-2 cells, among the various differentiation features of proximal tubules, retain also the expression of a functional PGP in their membranes and that both PGP activity and expression may be modulated by drugs. Therefore, HK-2 line appears a suitable and promising tool for the study in vitro of renal transport processes dependent on PGP.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Kidney Tubules, Proximal/metabolism , Blotting, Western , Calcium Channel Blockers/pharmacology , Cell Line , Cyclosporine/pharmacology , Enzyme Inhibitors/pharmacology , Fluorescent Antibody Technique , Fluorescent Dyes/pharmacology , Humans , Kidney Tubules, Proximal/cytology , Kidney Tubules, Proximal/drug effects , Rhodamine 123/pharmacology , Verapamil/pharmacology
4.
Pediatr Dermatol ; 16(3): 228-31, 1999.
Article in English | MEDLINE | ID: mdl-10383783

ABSTRACT

Potassium hydroxide (KOH) is a strong alkali that has long been known to digest proteins, lipids, and most other epithelial debris of skin scrapings to identify fungal infections. To our knowledge, KOH has never been used for the treatment of molluscum contagiosum (MC). We evaluated 35 children with MC for the clinical effectiveness of treatment with topical 10% KOH aqueous solution. The solution was applied by the parents of affected children, twice daily, on each MC lesion. The therapy was continued until all lesions underwent inflammation and superficial ulceration. Thirty-two of 35 patients achieved complete clinical cure after a mean treatment period of 30 days. Three children discontinued treatment: two reported severe stinging of the lesions and refused further applications; the other, with giant MC lesions, developed a secondary infection with prolonged treatment. Therapy with KOH was found to be effective and safe in the treatment of MC in children.


Subject(s)
Hydroxides/therapeutic use , Molluscum Contagiosum/drug therapy , Potassium Compounds/therapeutic use , Adolescent , Child , Child, Preschool , Female , Humans , Hydroxides/adverse effects , Hyperpigmentation/chemically induced , Hypertrophy/chemically induced , Hypopigmentation/chemically induced , Infant , Male , Potassium Compounds/adverse effects , Skin/drug effects , Skin/pathology , Treatment Outcome
5.
Life Sci ; 62(25): 2349-58, 1998.
Article in English | MEDLINE | ID: mdl-9651124

ABSTRACT

Curcumin is a natural phenolic compound found in the rhizomes of Curcuma longa and endowed with beneficial biological activities including antioxidant, anticarcinogenic and hepatoprotective effects. In this study curcumin was tested for its potential ability to interact in vitro with hepatic P-glycoprotein (Pgp), in a model system represented by primary cultures of rat hepatocytes, in which spontaneous overexpression of multidrug resistance (mdr) genes occurs. In both freshly-plated hepatocytes, containing low levels of Pgp, and 72 hour-cultured hepatocytes, containing high levels of Pgp, the Rhodamine-123 (R-123) efflux, which represents a specific functional test for Pgp-mediated transport, was inhibited by curcumin in a dose-dependent manner. Western blot analysis showed that 25microM curcumin, when included in the culture medium throughout the experimental observation (72 hours), was able to significantly lower the increase of mAb C219-immunoreactive protein spontaneously occurring in the cells during culture. Curcumin, at doses ranging from 50 to 150microM was cytotoxic for freshly-plated hepatocytes, as shown by the strong decrease in the cell ability to exclude trypan blue 24 hours later, but it was significantly less cytotoxic when added to 24 or 48 hour-cultured cells. The resistance to curcumin, progressively acquired by cells during culture, was significantly reduced by high concentrations of dexamethasone (DEX) or dimethyl-sulfoxide (DMSO), culture conditions known to inhibit the spontaneous overexpression of Pgp. In addition, in a concentration-dependent manner, verapamil reverted curcumin resistance in Pgp overexpressing hepatocytes. In photoaffinity labeling studies, curcumin competed with azidopine for binding to Pgp, suggesting a direct interaction with glycoprotein. These results suggest that curcumin is able to modulate in vitro both expression and function of hepatic Pgp and support the hypothesis that curcumin, a chemopreventive phytochemical, could reveal itself also as a compound endowed with chemosensitizing properties on mdr phenotype.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/drug effects , Anticarcinogenic Agents/pharmacology , Curcumin/pharmacology , Liver/drug effects , Analysis of Variance , Animals , Cell Survival/drug effects , Cells, Cultured , Coloring Agents , Dexamethasone/pharmacology , Dimethyl Sulfoxide/pharmacology , Drug Evaluation, Preclinical , Drug Resistance, Multiple/genetics , Liver/cytology , Liver/metabolism , Male , Rats , Rats, Sprague-Dawley , Verapamil/pharmacology
6.
Cir. vasc. angiol ; 13(2): 65-70, jun. 1997. ilus, tab
Article in Portuguese | LILACS | ID: lil-248164

ABSTRACT

A proposta deste estudo foi apresentar uma série de pacientes com doença oclusiva da artéria subclávia tratados por procedimento cirúrgico ou angioplastia. Durante um período de cinco anos, nove pacientes com idade média de 54 anos foram submetidos a seis derivaçöes carótidas-subclávias, uma endarterectomia e duas angioplastias. Os resultados clínicos foram inteiramente satisfatórios em quatro pacientes com sintomas cerebrais, em dois com isquemia de membro e em dois dos três com sintomas mistos. Um paciente faleceu e dois foram perdidos para seguimento. As reconstruçöes permaneceram pérvicas em cinco pacientes entre 12 e 28 meses de seguimento de seguimento mas ocluiu em outro. A revascularizaçäo das artérias subclávia é efetiva tanto com procedimentos cirúrgicos como com a angioplastia.


Subject(s)
Male , Female , Adult , Aged , Angioplasty , Arteriosclerosis Obliterans , Subclavian Artery , Subclavian Steal Syndrome , Blood Vessel Prosthesis , Treatment Outcome
7.
Life Sci ; 57(19): 1741-51, 1995.
Article in English | MEDLINE | ID: mdl-7475916

ABSTRACT

The effects of flavonols on P-glycoprotein (Pgp) activity were studied in cultured rat hepatocytes by assessing and transmembrane transport of Rhodamine-123 (R-123) and doxorubicin (DOX). In freshly-plated hepatocytes, containing a low amount of Pgp, flavonols did not affect the cellular retention of DOX, but strongly inhibited the Pgp-mediated efflux of R-123. In 72h-cultured hepatocytes, spontaneously overexpressing functional Pgp, flavonols inhibited R-123 efflux in a dose-dependent manner, but significantly reduced DOX retention while increasing its efflux. A similar effect was found in hepatocytes obtained from rats in which Pgp was induced in vivo by 2-acetamino-fluorene (AAF) or alpha-naphthyl-isothiocyanate (ANIT) treatments. These findings indicate that flavonols, dietary compounds reported to strongly upregulate the apparent activity of Pgp in cancer cell lines, may also modulate differently the transport of putative Pgp substrates in normal rat hepatocytes. The ability to affect the drug-extruding activity at the hepatocyte canalicular membrane could be of relevance to the chemopreventive action of these compounds towards liver carcinogens.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/drug effects , Flavonoids/pharmacology , Kaempferols , Liver/drug effects , 2-Acetylaminofluorene/pharmacology , ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis , Animals , Antibiotics, Antineoplastic/pharmacokinetics , Antimetabolites, Antineoplastic/pharmacokinetics , Blotting, Western , Cells, Cultured , Doxorubicin/pharmacokinetics , Drug Interactions , Flavonols , HL-60 Cells/drug effects , HL-60 Cells/metabolism , Humans , Liver/cytology , Liver/metabolism , Male , Quercetin/analogs & derivatives , Quercetin/pharmacology , Rats , Rats, Sprague-Dawley , Rhodamine 123 , Rhodamines/pharmacokinetics
8.
Cell Biol Toxicol ; 10(3): 163-6, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7994633

ABSTRACT

The amount and activity of the multi-drug transporter P-glycoprotein (Pgp) have been measured in cultured hepatocytes derived from different rat strains. A marked increase in Pgp, as revealed by Western blotting, occurred 48 h after seeding in hepatocytes from Sprague-Dawley, Wistar and Fischer 344 rats, the last showing the highest value. The addition of dexamethasone (DEX) to culture medium delayed Pgp overexpression in all the strains, proportionally to the protein amount in the absence of hormone. The R-123 functional test for Pgp showed that Fischer 344 hepatocytes had the lowest ability to extrude the fluorescent dye as compared with Sprague-Dawley or Wistar rats. These results suggest that the Fischer 344 rat is more prone than other strains to culture stressing conditions, leading to an overexpression of Pgp that is not necessarily functional.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis , Animals, Inbred Strains/genetics , Liver/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1/drug effects , Animals , Blotting, Western , Cells, Cultured , Dexamethasone/pharmacology , Fluorescent Dyes , Rats , Rats, Inbred F344 , Rats, Sprague-Dawley , Rats, Wistar
9.
Carcinogenesis ; 15(2): 335-41, 1994 Feb.
Article in English | MEDLINE | ID: mdl-7906206

ABSTRACT

Spontaneous and culture condition-dependent changes in P-glycoprotein expression and activity have been monitored in primary cultures of rat hepatocytes by using immunoblotting, PCR and fluorimetric techniques. In hepatocytes cultured in basal medium without addition of dexamethasone or 3-methylcholanthrene, mdr mRNA and P-glycoprotein increased progressively throughout a 72 h culture period, in concert with an enhancement in the ability to extrude the fluorescent dye Rhodamine-123. Addition of 1 microM dexamethasone to the culture medium slowed down the increase in mdr mRNA and P-glycoprotein, while inducing a significant increase in the efficiency of R-123 efflux. Addition of either 100 nM or 10 microM DEX produced different changes in mdr mRNA and protein, unrelated to the rate of Rhodamine-123 extrusion. When 50 microM 3-methylcholanthrene was added to the culture medium in the absence of any hormone supplementation, no significant changes in P-glycoprotein activity and expression took place, in comparison with control cultures. On the contrary, in the presence of dexamethasone (100 nM and 1 microM), 3-methylcholanthrene induced an increase in mdr mRNA and in the amount of immunoblottable protein during culture, without producing any concomitant increase in the efficiency to extrude Rhodamine-123. The last phenomenon resulted to be an artefact, since 3-methylcholanthrene was shown to inhibit Rhodamine-123 transport competitively. These results indicate that rat hepatocyte P-glycoprotein may be variously modulated in vitro, by supplementing culture medium with hormones and/or xenobiotics. Functional activity of the P-glycoprotein is not necessarily related with protein amount and/or mdr RNA.


Subject(s)
Carrier Proteins/biosynthesis , Dexamethasone/pharmacology , Liver/drug effects , Membrane Glycoproteins/biosynthesis , Methylcholanthrene/pharmacology , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Animals , Base Sequence , Cells, Cultured , DNA Primers , Drug Resistance , Liver/cytology , Liver/metabolism , Male , Molecular Sequence Data , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley
11.
An. bras. dermatol ; 59(4): 202-8, 1984.
Article in Portuguese | LILACS | ID: lil-22993

ABSTRACT

Neste estudo foram incluidos 148 doentes, sendo 65 com pitiriase versicolor e 83 com dermatofitoses, submetidos a tratamento com ketoconazole por via oral. A dose diaria foi de 200mg (um comprimido) durante duas a quatro semanas para os casos de pitiriase versicolor e de quatro a oito semanas para os de dermatofitoses. O tratamento determinou, nos doentes de pitiriase versicolor, cura clinica e micologica em 50 (78,1%), apenas cura clinica em dois (3,1%) e cura micologica em um (1,6%). Nos doentes com dermatofitoses, em 69 (84,1%) houve cura clinica e micologica, quatro (4,9%) apresentaram cura micologica e cinco (6,1%) tiveram apenas cura clinica. Efeitos colaterais foram observados em 11 doentes (7,4%), sendo que dois necessitaram abandonar o tratamento por intolerancia (um teve nauseas de grau moderado e outro, nauseas, vomitos e tonturas de grau moderado, ambos no 1o. dia de tratamento).O ketoconazole por via oral demonstrou ser bastante eficaz no tratamento de pitiriase versicolor e de dermatofitoses


Subject(s)
Adult , Middle Aged , Humans , Male , Female , Dermatomycoses , Ketoconazole
SELECTION OF CITATIONS
SEARCH DETAIL
...